The Cas9 mouse model of skull base meningioma generated with the Nf2 genetic defect and the combinational loss of P15Ink4b, P16Ink4a, and P19Arf could provide a new tool for investigating the pathogenesis of meningioma and the development of chemical interventions for this disease. This evidence concerns the gene NF2 and skull base meningioma.